These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 11504089

  • 21. Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM.
    Acton PD, Kung MP, Mu M, Plössl K, Hou C, Siciliano M, Oya S, Kung HF.
    Eur J Nucl Med; 1999 Aug; 26(8):854-61. PubMed ID: 10436198
    [Abstract] [Full Text] [Related]

  • 22. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG, Müller TT, Zander C, Kuhn W, Farahati J, Reiners C, Coenen HH.
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [Abstract] [Full Text] [Related]

  • 23. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents.
    Dahlström M, Ahonen A, Ebeling H, Torniainen P, Heikkilä J, Moilanen I.
    Mol Psychiatry; 2000 Sep; 5(5):514-22. PubMed ID: 11032385
    [Abstract] [Full Text] [Related]

  • 24. Comparison of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane for imaging of the dopamine transporter in the living human brain.
    Kuikka JT, Bergström KA, Ahonen A, Hiltunen J, Haukka J, Länsimies E, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Apr; 22(4):356-60. PubMed ID: 7607268
    [Abstract] [Full Text] [Related]

  • 25. Differential kinetics of [123I]beta-CIT binding to dopamine and serotonin transporters.
    Fujita M, Takatoku K, Matoba Y, Nishiura M, Kobayashi K, Inoue O, Nishimura T.
    Eur J Nucl Med; 1996 Apr; 23(4):431-6. PubMed ID: 8612664
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype.
    van Dyck CH, Malison RT, Staley JK, Jacobsen LK, Seibyl JP, Laruelle M, Baldwin RM, Innis RB, Gelernter J.
    Am J Psychiatry; 2004 Mar; 161(3):525-31. PubMed ID: 14992979
    [Abstract] [Full Text] [Related]

  • 28. Characterization of [(123)I]IDAM as a novel single-photon emission tomography tracer for serotonin transporters.
    Kung MP, Hou C, Oya S, Mu M, Acton PD, Kung HF.
    Eur J Nucl Med; 1999 Aug; 26(8):844-53. PubMed ID: 10436197
    [Abstract] [Full Text] [Related]

  • 29. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour.
    Tiihonen J, Kuikka JT, Bergström KA, Karhu J, Viinamäki H, Lehtonen J, Hallikainen T, Yang J, Hakola P.
    Eur J Nucl Med; 1997 Oct; 24(10):1253-60. PubMed ID: 9323266
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain].
    Takano K, Matsumura K, Watanabe Y, Yamada T, Kubo H, Naitou Y, Narita Y, Kuzuhara S, Takeda K.
    Kaku Igaku; 1999 Dec; 36(9):1013-22. PubMed ID: 10659586
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Iodine-123 labelled N-(2-fluoroethyl)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane for dopamine transporter imaging in the living human brain.
    Kuikka JT, Akerman K, Bergström KA, Karhu J, Hiltunen J, Haukka J, Heikkinen J, Tiihonen J, Wang S, Neumeyer JL.
    Eur J Nucl Med; 1995 Jul; 22(7):682-6. PubMed ID: 7498231
    [Abstract] [Full Text] [Related]

  • 34. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
    Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R.
    Biol Psychiatry; 2000 Mar 01; 47(5):371-9. PubMed ID: 10704949
    [Abstract] [Full Text] [Related]

  • 35. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.
    Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA.
    Eur J Nucl Med; 1998 Jan 01; 25(1):24-30. PubMed ID: 9396871
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reduced central serotonin transporters in alcoholism.
    Heinz A, Ragan P, Jones DW, Hommer D, Williams W, Knable MB, Gorey JG, Doty L, Geyer C, Lee KS, Coppola R, Weinberger DR, Linnoila M.
    Am J Psychiatry; 1998 Nov 01; 155(11):1544-9. PubMed ID: 9812115
    [Abstract] [Full Text] [Related]

  • 39. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D.
    J Nucl Med; 1996 Nov 01; 37(11):1760-5. PubMed ID: 8917170
    [Abstract] [Full Text] [Related]

  • 40. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G, Brücke T, Odin P, Brooks DJ, Kolbe H, Gielow P, Harke H, Knoop BO, Dengler R, Knapp WH.
    Nuklearmedizin; 2003 Feb 01; 42(1):31-8. PubMed ID: 12601452
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.